Cathay Capital Invests in Ascendia Autism Care to Expand Access to Evidence-Based ABA Therapy for Children and Families

Rhea-AI Summary

Cathay Capital launched Ascendia Autism Care, a platform focused on expanding access to evidence-based ABA therapy for children with autism and their families. Ascendia starts with a founding affiliate operating 20 centers across eight states and plans further de novo growth and provider partnerships.

Ascendia employs 400+ clinicians, including over 70 BCBAs and 300+ RBTs, reports a 4.2-star family satisfaction rating, and targets early intervention for ages two to six. Gladstone Capital (NASDAQ: GLAD) participated as a capital partner in the transaction.

News Market Reaction – GLAD

-0.15%

-0.15% Session close to close

In the Jun 30 session, GLAD declined 0.15%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement links GLAD to Cathay Capital’s backing of Ascendia’s ABA expansion, highlighting e...

Analysis

This announcement links GLAD to Cathay Capital’s backing of Ascendia’s ABA expansion, highlighting exposure to autism care demand. Prior note offerings and low short interest support balance-sheet flexibility, but portfolio credit quality and deployment pace remain key watch points.

Key Figures

ABA centers: 20 centers Clinical team size: More than 400 clinicians Board Certified Behavior Analysts: Over 70 BCBAs +5 more

8 metrics

ABA centers 20 centers Founding affiliate operations across eight U.S. states

Clinical team size More than 400 clinicians Ascendia Autism Care workforce across ABA therapy programs

Board Certified Behavior Analysts Over 70 BCBAs Part of Ascendia’s ABA clinical team

Registered Behavior Technicians More than 300 RBTs Providing center-based ABA therapy at Ascendia

Family satisfaction rating 4.2-star rating Reported satisfaction for Ascendia’s services

Autism prevalence 1 in 31 children Estimated U.S. prevalence of autism spectrum disorder (CDC)

Notes offering $60.0 million 7.000% unsecured notes due 2029 per 424B2 filing

Estimated net proceeds $58.7 million From 7.000% notes due 2029 to repay debt and fund investments

Historical Context

4 past events · Latest: Jun 02 (Neutral)

Pattern 4 events

Date	Event	Sentiment	24h Move	Catalyst
Jun 02	Board election	Neutral	-0.4%	Election of new director expanding board size and committee participation.
May 06	Earnings results	Neutral	+4.1%	Q2 2026 financial results, portfolio activity and common distributions announcement.
May 05	Earnings call info	Neutral	+0.6%	Scheduling and access details for upcoming Q2 2026 earnings call and webcast.
Apr 14	Distributions & call	Neutral	+3.0%	Monthly cash distributions for Q2 2026 and related earnings call timing.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

GLAD shares have generally reacted with modest gains following recent corporate and earnings announcements, with only one small negative move.

Key Terms

applied behavior analysis, aba therapy, autism spectrum disorder, board certified behavior analysts, +1 more

5 terms

applied behavior analysis medical

"a new platform dedicated to expanding access to evidence-based Applied Behavior Analysis (ABA) therapy"

Applied behavior analysis is a scientific method for changing behavior by observing what triggers and rewards actions, then systematically teaching and reinforcing more useful behaviors. Investors track it because it drives demand, costs and regulatory scrutiny for providers that deliver therapy — much like a proven production process shapes a factory’s output, ABA’s techniques determine staffing needs, reimbursement rates, measurable outcomes and the scalability of care services.

aba therapy medical

"expanding access to evidence-based Applied Behavior Analysis (ABA) therapy for children"

Applied Behavior Analysis (ABA) therapy is a structured, evidence-based approach that breaks skills into small steps, uses repetition and positive reinforcement to teach useful behaviors, and reduces harmful or unhelpful ones—most commonly used for people with autism and developmental differences. Investors care because changes in demand, insurance coverage, regulation, or availability of trained staff affect revenue and margins for clinics, therapy networks, schools and insurers; think of it as a service whose growth depends on both patient need and how it gets paid for.

autism spectrum disorder medical

"children with autism spectrum disorder and their families"

A neurodevelopmental condition that affects how a person communicates, interacts socially, and responds to sensory input and routine; it varies widely from mild to more pronounced differences, like colors on a gradient rather than a single shade. Investors care because prevalence, diagnostic tools, therapies, educational and workplace accommodations, and regulatory approvals shape demand, revenue potential, and risk for healthcare, biotech, education, and technology companies focused on services or products for people on the spectrum.

board certified behavior analysts medical

"includes over 70 Board Certified Behavior Analysts (BCBAs) and more than 300 Registered Behavior Technicians"

Board certified behavior analysts are professionals who have completed graduate-level training, supervised clinical hours, and a national exam in applied behavior analysis, a structured method for changing behavior in schools, clinics, and homes. For investors, the credential signals consistent treatment quality, stronger reimbursement and licensing prospects, and greater customer trust—similar to how a certified technician increases a service business’s credibility, pricing power, and ability to scale.

registered behavior technicians medical

"over 70 Board Certified Behavior Analysts (BCBAs) and more than 300 Registered Behavior Technicians (RBTs)"

Registered Behavior Technicians (RBTs) are certified, frontline therapy providers who carry out behavioral treatment plans designed by a licensed behavior analyst; think of them as trained technicians who follow a clinician’s playbook to teach skills and reduce problem behaviors. Investors care because the number, quality and retention of RBTs affect a provider’s ability to deliver services reliably, comply with regulations and generate billable revenue—key factors for growth and reimbursement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW YORK, June 30, 2026 /PRNewswire/ -- Cathay Capital announced the launch of Ascendia Autism Care, a new platform dedicated to expanding access to evidence-based Applied Behavior Analysis (ABA) therapy for children with autism spectrum disorder and their families. Ascendia begins operations with a founding affiliate that operates 20 centers across eight states, with plans for continued growth through de novo expansion and additional partnerships with leading clinical providers. Cathay Capital's investment is sized to fund both the founding transaction and substantial growth capital for the platform's continued expansion. Financial terms were not disclosed.

An estimated one in 31 children in the United States has been identified with autism spectrum disorder, according to the Centers for Disease Control and Prevention. Demand for ABA therapy continues to outpace supply, and in many communities, families wait months to begin services. ABA is recognized by the U.S. Surgeon General as evidence-based and is now covered by commercial insurance and Medicaid in all 50 states. Yet, access varies sharply by geography and community. The company is committed to narrowing that gap with a clinician-first model centered on outcomes for children and the families who care for them.

Ascendia delivers center-based ABA therapy with a focus on early intervention for children ages two to six. Its clinical team of more than 400 includes over 70 Board Certified Behavior Analysts (BCBAs) and more than 300 Registered Behavior Technicians (RBTs), supported by clinical supervision standards that prioritize close BCBA oversight of each child's program. The affiliate reports a 4.2-star family satisfaction rating.

The company has grown rapidly in recent years, driven by strong organic demand from families and the consistent opening of new clinics. With Cathay Capital's support, Ascendia plans to broaden access in its existing markets and adjacent communities, with new centers planned in all markets over the next 24 months. The platform will continue investing in its clinical workforce and expanding into adjacent channels, including schools and school districts, to deliver autism therapy in educational settings where children spend much of their day. These school-based programs allow families, educators, and clinicians to coordinate more closely around each child's goals and progress.

"Family-centered providers represent the kind of mission-driven, clinically rigorous business we are proud to back," said Mark Woods, Partner, Head of North American Private Equity at Cathay Capital. "Our role is to provide the resources and operating support to extend their work to more children and families, at the same level of quality that has earned them the trust they have today. ABA is a long-term commitment to children, families, and the dedicated clinicians who serve them. We are focused on supporting that mission."

"There is a significant unmet need for ABA therapy for children with autism spectrum disorder and evidence demonstrating the clear benefits of early, comprehensive intervention," said Jackson Catalano, Vice President at Cathay Capital. "Through our partnership with Ascendia, we aim to expand access to high-quality care, create continued opportunities for clinicians and employees, and support a best-in-class clinical experience for the children and families Ascendia serves."

Gladstone Capital Corporation (NASDAQ: GLAD) was a capital partner in the transaction, Berkery Noyes served as financial advisor, and Haynes Boone served as legal counsel to Cathay Capital.

About Ascendia Autism Care

Ascendia Autism Care is a clinician-led platform investing in and partnering with leading providers of ABA therapy. Ascendia partners with operators who share a commitment to clinical quality, family experience, and expanding access for the children and families who need care. The platform was launched in 2026 with the backing of Cathay Capital. For more information, visit: www.ascendiaaustismcare.com.

About Cathay Capital

Cathay Capital is a global private equity and venture capital investment firm supporting healthcare, technology and consumer companies throughout North America, Europe, and Asia. The firm helps middle-market companies and startups navigate opportunities for growth, international expansion, and sustainable transformation. Cathay is the partner of choice for companies aspiring to lead markets and make a positive impact. Its platform connects people with global reach and local expertise – from investors and entrepreneurs to management teams and leading corporations – to share knowledge, the tools to scale and to transform businesses.

Founded in 2007 with a strong entrepreneurial heritage, Cathay Capital now manages more than $5.5 billion in assets. It has made over 250 investments in verticals including healthcare, technology, and consumer from offices in New York, San Francisco, Paris, Munich, Berlin, Madrid, Shanghai, Beijing, Shenzhen, and Singapore. For more information, visit: www.cathaycapital.com.

About Gladstone Capital Corporation

Gladstone Capital Corporation is a publicly-traded business development company that invests in debt and equity securities, consisting primarily of secured first and second lien term loans to lower middle market businesses in the United States. For more information, please visit www.gladstonecapital.com.

Media Contact:

Mary Magnani
CodePR
marym@codepr.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/cathay-capital-invests-in-ascendia-autism-care-to-expand-access-to-evidence-based-aba-therapy-for-children-and-families-302813949.html

SOURCE Cathay Capital

FAQ

What is Ascendia Autism Care and how is it connected to Gladstone Capital (NASDAQ: GLAD)?

Ascendia Autism Care is a new ABA therapy platform launched by Cathay Capital to expand autism services for children and families. According to Cathay Capital, Gladstone Capital (NASDAQ: GLAD) participated as a capital partner in the transaction supporting Ascendia’s founding and planned growth.

How many ABA therapy centers does Ascendia Autism Care operate as of June 30, 2026?

As of June 30, 2026, Ascendia Autism Care begins operations with a founding affiliate running 20 centers across eight states. According to Cathay Capital, these center-based clinics focus on early intervention ABA therapy for children ages two to six and plan continued expansion.

What are Ascendia Autism Care’s growth plans over the next 24 months?

Ascendia Autism Care plans to broaden access through de novo centers and additional clinical partnerships in current and adjacent markets. According to Cathay Capital, new centers are planned in all markets over the next 24 months, alongside expansion into school-based ABA programs for children.

What clinical team does Ascendia Autism Care have to deliver ABA therapy services?

Ascendia Autism Care’s clinical team exceeds 400 professionals, including over 70 Board Certified Behavior Analysts and more than 300 Registered Behavior Technicians. According to Cathay Capital, the model emphasizes close BCBA oversight of each child’s program and currently reports a 4.2-star family satisfaction rating.

How does Ascendia Autism Care aim to improve access to ABA therapy in underserved communities?

Ascendia Autism Care focuses on expanding ABA therapy where demand exceeds supply and waitlists are common. According to Cathay Capital, the platform uses a clinician-first, outcomes-focused model, plans de novo centers, and is extending services into schools to better reach children in educational settings.

Why did Cathay Capital invest in Ascendia Autism Care’s ABA therapy platform?

Cathay Capital invested to support a mission-driven, family-centered ABA provider addressing significant unmet autism care needs. According to Cathay Capital, the investment funds the founding transaction and substantial growth capital, aiming to expand high-quality early intervention and create opportunities for clinicians and employees.